Post #: 12548937
This post goes back to 2013 but a big name in there leaves me with a sneaking suspicion that Novartis could well be someone willing to play
What "exclusive license and development agreement" actually means could also be up for interpretation
My scientific wild ass guess is that there might well be some assistance financially to complete the trials and the exclusivity kicks in at determined end pointsThats my SWAG
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $14.28M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $2.55K | 511.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 18250625 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27692966 | 23 |
View Market Depth
| Last trade - 12.03pm 25/07/2025 (20 minute delay) ? |
| AVE (ASX) Chart |